Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion type Assertion NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_head.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion description "[Our data indicate that gene polymorphism of CCR2 V64I may influence the susceptibility and clinicopathological characteristics of prostate cancer and CCR5 ?32 allele may also be an important risk factor for prostate cancer in Turkish men population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion evidence source_evidence_literature NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion SIO_000772 22612293 NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion wasDerivedFrom befree-20140225 NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.
- NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_assertion wasGeneratedBy ECO_0000203 NP324173.RABQtlFiDFLAkyl8-nxz4bq1zC3TZ6jAGRbGzxg-dlI0I130_provenance.